Navigation Links
At the 2007 Alzheimer's Association International Conference on the,Prevention of Dementia - Neurochem's U.S. Principal Investigator,Presents Update on Tramiprosate (Alzhemed)

y Rat Neurons by a GABA-Independent Pathway in presentation P-192. About Neurochem

Neurochem Inc. is focused on the development and commercialization of innovative therapeutics to address critical unmet medical needs. Eprodisate (KIACTA(TM)) is currently being developed for the treatment of Amyloid A (AA) amyloidosis, and is under regulatory review for marketing approval by the United States Food and Drug Administration, European Medicines Agency and Swissmedic. Tramiprosate (ALZHEMED(TM)), for the treatment of Alzheimer's disease, has completed a Phase III clinical trial in North America and is currently in a Phase III clinical trial in Europe, while tramiprosate (CEREBRIL(TM)), for the prevention of Hemorrhagic Stroke caused by Cerebral Amyloid Angiopathy, has completed a Phase IIa clinical trial.

To Contact Neurochem

For additional information on Neurochem and its drug development programs, please call the North American toll-free number 1 877 680-4500 or visit our Web Site at: www.neurochem.com.

This news release contains forward-looking statements regarding tramiprosate (ALZHEMED(TM)) as well as regarding continuing and further development efforts. These statements are based on the current analysis and expectations of management. Drug development necessarily involves numerous risks and uncertainties, which could cause actual results to differ materially from this current analysis and these expectations. Analysis regarding the results of clinical trials may not provide definitive results regarding safety, tolerability or therapeutic benefits. Even if all the endpoints sought in the clinical trials were met (which is not certain), there is no certainty that regulators would ultimately approve tramiprosate (ALZHEMED(TM)) for sale to the public. Risks and uncertainties may include: failure to demonstrate the safety, tolerability and efficacy of our product, that ac
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
2. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
3. Accera, Inc. Announces Open-Label Data from Phase II Study in Alzheimers Disease at International Conference on Prevention of Dementia
4. Myriad Genetics Presents Mathematical Comparison of Disease Modification Trial Designs at Alzheimers ConferenceCurrent Flurizan Phase 3 Study Design May Demonstrate Disease Modification
5. Treating Heart Disease Risk Factors May Slow Alzheimers Disease Progression
6. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
7. Clinical Update - Debio 9902 (ZT-1) for Alzheimers Disease
8. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
9. Medivation Announces Presentation of New Subset Analyses From Dimebon Phase 2 Alzheimers Disease Trial at American Academy of Neurology Annual Meeting
10. Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the Treatment of Alzheimers Disease
11. Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimers Drug
Post Your Comments:
(Date:9/2/2015)... BOULDER, Colo. , Sept. 2, 2015 /PRNewswire/ ... announced that its Chief Executive Officer, Ron ... Securities Healthcare Conference in Boston.  The public is ... webcast on the Array BioPharma website.Event: Wells Fargo ... , Thursday, September 10, 2015Time:  , 10:20 a.m. ...
(Date:9/2/2015)... STAAR Surgical Company (NASDAQ: STAA ), a ... systems for the eye, today announced that its Board of ... Company,s Board. Mr. Wall was formerly the ... -based investment firm, for more than nine years. Mr. Wall ... chair of the Corporate Governance Committee and member of the ...
(Date:9/2/2015)... , Sept. 2, 2015 Amgen ... of a Marketing Authorization Application (MAA) to the ... for etelcalcetide (formerly AMG 416) for the treatment ... chronic kidney disease (CKD) on hemodialysis therapy. If ... that can be administered intravenously. Etelcalcetide ...
Breaking Medicine Technology:William P. Wall Appointed to STAAR Surgical Board of Directors 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 2Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 3Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 4Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 5Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 6Amgen Submits Marketing Authorization Application For Novel Intravenous Calcimimetic Etelcalcetide (AMG 416) To The European Medicines Agency 7
... 30 Cornerstone Therapeutics Inc. (Nasdaq: CRTX ... and commercializing significant products primarily for the respiratory and ... Price , Executive Vice President and Chief Financial Officer, ... financial officer position at another public company.  Mr. Price,s ...
... DALLAS , June 29 The Thermal Angel Blood and ... hospitals , military and emergency responders around the ... "Outstanding Military Product of the Year" by the Institute for Defense and Government ... , , ...
Cached Medicine Technology:Cornerstone Therapeutics Announces Management Change 2Cornerstone Therapeutics Announces Management Change 3Award-Winning Thermal Angel Selected as Winner for 'Outstanding Military Product of the Year' 2Award-Winning Thermal Angel Selected as Winner for 'Outstanding Military Product of the Year' 3Award-Winning Thermal Angel Selected as Winner for 'Outstanding Military Product of the Year' 4
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, ... announced the two leaders who will deliver keynote presentations at the upcoming Digital ... Mandarin Oriental Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver ...
(Date:9/2/2015)... ... September 02, 2015 , ... Based in Beverly Hills, Luxury ... truly superb luxury vehicles based on which of the latest and greatest vehicles their ... step forward in pursuit of this goal: a 2015 Rolls Royce Wraith rental ...
(Date:9/2/2015)... ... September 02, 2015 , ... The Western ... and Mildred Goldstein Charitable Trust to establish the Abraham and Mildred Goldstein Endowment ... months after WCHN recruited nationally known gynecologic oncologist Thomas J. Rutherford, MD, PhD ...
(Date:9/2/2015)... ... 2015 , ... Date and time: Oct. 3, 2015, 9 a.m. to 4 ... Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The ... best-selling author Sam Keen based on his new book which he co-authored with his ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... safety and efficacy endpoint data collection, cloud analytics and workflow solutions today ... The series enables pharmaceutical researchers to participate in interactive programs in which ...
Breaking Medicine News(10 mins):Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:Luxury Line Auto Rental Announces Addition of the Rolls Royce Wraith to their Luxury Fleet 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 2Health News:Western Connecticut Health Network Receives $1 Million Gift to Establish Ovarian Cancer Research Endowment 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 2Health News:ERT Announces Web Seminar Series on Optimizing Trial Data Collection & Gaining Real-Time Data Insights 3
... Dec. 2 TROY Group, Inc.,(Pink Sheets: TROY), ... the first digital printer for printing the federally,mandated ... TROY SecureRx,printer allows healthcare providers to significantly reduce ... security regulations,established by the Center for Medicare and ...
... SAN JOSE, Calif., Dec. 2 eOn Communications,Corporation(TM) (Nasdaq: ... announced today that it has received a contract from ... at the Landstuhl Regional Medical,Center in Germany. Implementation ... April of 2009. , ...
... Shower(TM) brand just got,better with the addition of its new ... flavor contains Lifeguard(TM) Protection, a fortification,package with powerful antioxidant vitamins ... leading brands. , "We ... Sun Shower(TM) Super,Blends iced coffees, teas and lattes," said Chris ...
... SACRAMENTO, Calif., Dec. 2 MRME the publisher of ... the American,College of Cardiology (CA ACC), the largest ACC ... and impactful educational programs for,cardiologists. The CA ACC is ... of medical education activities. , ...
... and improves attention to the scan, study shows , , TUESDAY, ... the patient next to their radiological scans helps humanize each ... by radiologists, a new study finds. , As technological ... patient, putting a patient,s photo in his or her file ...
... MANCHESTER, N.H., Dec. 2 Anthem Blue Cross and ... have pledged more than,$175,000 to support over 220 not-for-profit ... Giving Campaign. The Anthem Blue Cross and Blue,Shield Foundation ... the total to more than $260,000 , ...
Cached Medicine News:Health News:TROY SecureRx Revolutionizes Prescription Printing 2Health News:TROY SecureRx Revolutionizes Prescription Printing 3Health News:TROY SecureRx Revolutionizes Prescription Printing 4Health News:eOn Communications Announces GSA Contract 2Health News:eOn Communications Announces GSA Contract 3Health News:New Sun Shower(TM) Super Blends: Iced Coffees, Teas, Lattes With Half the Calories 2Health News:Patients' Photos Help Boost Radiologists' Accuracy 2Health News:Anthem Blue Cross and Blue Shield in New Hampshire Associates Pledge More Than $260,000 to Community Organizations 2Health News:Anthem Blue Cross and Blue Shield in New Hampshire Associates Pledge More Than $260,000 to Community Organizations 3
Trial lens set +/- Cyl....
...
... of engineering and innovative design, the Burton ... and masterful workmanship. At Burton, we set ... industry a truly innovative concept, but to ... to quality construction and stringent testing, we ...
... Durable cast iron and steel construction for ... quiet and reliable up/down chair movement. Soft, ... of lasting comfort. Electro-magnetic counter-balanced slit lamp ... Low, only 24" high slit lamp arm ...
Medicine Products: